Prognia
Drug Database
🇪🇺EU · EMAAuthorisedATC: J05AF05

Epivir(lamivudine)

HIV Infections

Marketing Authorisation Holder: ViiV Healthcare BV

EMA Authorisation: 08/08/1996

INN: lamivudine

Indication

Epivir is indicated as part of antiretroviral combination therapy for the treatment of human-immunodeficiency-virus (HIV)-infected adults and children.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Epivir — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.